Search
for

    Sort by

    Research 31–60 of 1000+

    1. Management of diffuse alopecia CRC Press eBooks · 2015
    2. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertility and Sterility · 2008 · 1540 citations
    3. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome European journal of endocrinology · 2009 · 200 citations
    4. Comorbidities in alopecia areata: A systematic review and meta-analysis Journal of The American Academy of Dermatology · 2018 · 100 citations
    5. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome Urology · 2018 · 35 citations
    6. Polycystic Ovarian Syndrome: Long-Term Health Consequences Seminars in Reproductive Medicine · 2017 · 34 citations
    7. Guidelines for the Use of Acitretin in Psoriasis Actas Dermo-Sifiliográficas · 2013 · 25 citations
    8. Congenital Adrenal Hyperplasia Pediatrics in Review · 2009 · 13 citations
    9. Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives Saudi Pharmaceutical Journal · 2024 · 3 citations
    10. Hirsutism in Children: A Comprehensive Review of Etiology, Clinical Evaluation and Contemporary Management World Journal of Biology Pharmacy and Health Sciences · 2025 · 1 citations
    11. Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2018 · 1 citations
    12. The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them? MAEDICA – a Journal of Clinical Medicine · 2025
    13. Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management International Journal of Pharmaceutical Research and Applications · 2025
    14. Factors associated with early-onset androgenetic alopecia: A scoping review PLOS ONE · 2024
    15. An Overview of Harmful Effects of Polycystic Ovary Syndrome Journal of oncology research reviews & reports · 2021
    16. History and physical examination of polycystic ovary syndrome: Detecting too much or too little Cambridge University Press eBooks · 2015
    17. The polycystic ovary syndrome Obstetrics & gynecology science · 2008
    18. Viewpoint 3 Experimental dermatology · 2008
    19. Androgenetic Alopecia From A to Z Springer eBooks · 2022
    20. Testosterone therapy for transgender men The Lancet Diabetes & Endocrinology · 2016 · 162 citations
    21. PATHOGENETIC FEATURES OF THE INFLUENCE OF A PAST CORONAVIRUS INFECTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME Sibirskij medicinskij vestnik · 2023
    22. Secondary Copper deficiency associated dermatitis in Goats: Insights from hematobiochemical, mineral and histopathological investigation. Journal of Livestock Science · 2026
    23. RECENT DEVELOPMENTS IN ALOPECIAS International Journal of Dermatology · 1978 · 7 citations
    24. Early Androgenetic Alopecia as a Metabolic Signal, Not Yet a Diabetes Predictor Journal of the American Academy of Dermatology · 2026
    25. Skin as a mirror of metabolic syndrome: Do some dermatoses alarm internal metabolic sinister? IP Indian Journal of Clinical and Experimental Dermatology · 2024
    26. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome Human Reproduction Update · 2009 · 286 citations
    27. Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India Indian Journal of Endocrinology and Metabolism · 2014 · 22 citations
    28. Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks Humana Press eBooks · 2008
    29. Study of cardiovascular risk factors in patients with androgenetic alopecia: Metabolic syndrome and carotid atheromatosis Journal of The American Academy of Dermatology · 2009
    30. Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome Nature Clinical Practice Endocrinology & Metabolism · 2005 · 69 citations